Publications

*Denotes co-first author; ⁺Denotes corresponding author; Featured publications are underlined

1. M.J. Lee, et al. NK cell-monocyte crosstalk underlies NK cell activation in severe COVID-19. bioRxiv (2023).
2. S. Dzanibe, A.J. Wilk, et al. Disrupted memory T cell expansion in HIV-exposed uninfected infants is preceded by premature skewing of T cell receptor clonality. bioRxiv (2023).
3. A.J. Wilk, et al. Pro-inflammatory feedback loops define immune responses to pathogenic lentivirus infection. bioRxiv (2023).
4. A.J. Wilk⁺, A.K. Shalek, S. Holmes, and C.A. Blish. Comparative analysis of cell-cell communication at single-cell resolution. Nat Biotech (2023).
   • Software package: Scriabin
   • Preprint: bioRxiv
   • Research briefing: Nat Biotech
   • Highlight: D. Clyde, Single cell-cell communication. Nat Rev Genetics (2023)
5. K. Ratnasiri*, A.J. Wilk*, M.J. Lee*, et al. Single-cell RNA-seq methods to interrogate virus-host interactions. Semin Immunolpathol (2022).
6. X. Jia*, et al. Anti-nucleocapsid antibody levels and pulmonary comorbid conditions are linked to post–COVID-19 syndrome. JCI Insight (2022).
7. T.T-H. Wu*, et al. Activated interstitial macrophages are a predominant target of viral takeover and focus of inflammation in COVID-19 initiation in human lung. bioRxiv (2022).
8. N. Ram-Mohan, et al. Detection of bacterial co-infections and prediction of fatal outcomes in COVID-19 patients presenting to the emergency department using a 29 mRNA host response classifier. medRxiv (2022).
9. C. Wang, et al. CRISPRa screening with real world evidence identifies potassium channels as neuronal entry factors and druggable targets for SARS-CoV-2. bioRxiv (2021).
10. A.J. Wilk*, M.J. Lee*, B. Wei*, B. Parks*, et al. Multi-omic profiling reveals widespread dysregulation of innate immunity and hematopoiesis in COVID-19. J Exp Med (2021).
    • Preprint: bioRxiv
11. N. Ram-Mohan, et al. SARS-CoV-2 RNAemia predicts clinical deterioration and extrapulmonary complications from COVID-19. Clin Infect Dis. (2021).
    • Preprint: medRxiv
12. C.S. Delaveris, A.J. Wilk, et al. Synthetic Siglec-9 Agonists Inhibit Neutrophil Activation Associated with COVID-19. ACS Central Science (2021).
    • Preprint: chemRxiv
13. Y. Hao*, et al. Integrated analysis of multimodal single-cell data. Cell (2021).
    • Preprint: bioRxiv
    • Press: The Medical News (2020).
14. A.J. Wilk*, A. Rustagi*, N.Q. Zhao*, et al. A single-cell atlas of the peripheral immune response in patients with severe COVID-19. Nature Medicine, 26, 7 (2020).
    • Preprint: medRxiv
    • Highlight: Salome, et al. Nature Reviews Immunology (2020).
    • Press: Yale Scientific, Nature Microbiology Community (2020).
15. A.J. Wilk*, N.L-B. Weidenbacher*, et al. Charge-altering releasable transporters enable phenotypic manipulation of natural killer cells for cancer immunotherapy. Blood Advances,4, 17 (2020).
    • Preprint: bioRxiv
16. A.J. Wilk and C.A. Blish. Diversification of human NK cells: Lessons from deep profiling. J Leukoc Biol, 103, 4 (2018).
17. M.A. Bone*, A.J. Wilk*, et al. Bordetella PlrSR regulatory system controls BvgAS activity and virulence in the lower respiratory tract. Proc. Natl. Acad. Sci. U.S.A., 114, 8 (2017).